Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | HTR7 | P34969 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.51 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28297946 | 0.90 | LMNA (0.69) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL11049972 | 0.85 | CYP1A2 (0.68) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL30947438 | 0.85 | LMNA (0.78) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL961132 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL891366 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL2149052 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL30546561 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL763166 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL21729878 | 0.82 | LMNA (0.64) | LMNAHPGDHTTALDH1A1MAPT | |
| SCHEMBL29695523 | 0.82 | CYP1A2 (0.74) | LMNAHPGDHTTALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3666757-A1 | PROCESS FOR PREPARING A PIPERIDIN-4-ONE | Karl-Franzens-Universität Graz (AT) | 2020-06-17 | — | — | EP | claimed |
| EP-3666757-A1 | PROCESS FOR PREPARING A PIPERIDIN-4-ONE | Karl-Franzens-Universität Graz (AT) | 2020-06-17 | — | — | EP | disclosed |
| US-6911442-B1 | Quinoline derivatives as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2005-06-28 | — | — | US | disclosed |
| EP-1187828-B1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2004-04-21 | — | — | EP | disclosed |
| EP-1187828-A1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2002-03-20 | — | — | EP | disclosed |
| CN-1285828-A | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom | SCHERING CORP (US) | 2001-02-28 | — | — | CN | disclosed |
| WO-2000078748-A1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-12-28 | — | — | WO | disclosed |
| EP-1028956-A1 | IMIDAZOYLALKYL SUBSTITUTED WITH A FIVE, SIX OR SEVEN MEMBERED HETEROCYCLIC RING CONTAINING ONE NITROGEN ATOM | SCHERING CORPORATION (US) | 2000-08-23 | — | — | EP | disclosed |
| US-6100279-A | HISTAMINE-H3 RECEPTOR ANTAGONIST; ANTIALLERGENIC AGENTS, ANTIASTHMATICS | SCHERING CORPORATION (US) | 2000-08-08 | — | — | US | disclosed |
| US-5932596-A | NOVEL COMPOUNDS HAVING ANTAGONIST OR AGONIST ACTIVITY ON H3 RECEPTORS AND PHARMACEUTICAL COMPOSITIONS THEREOF; USE FOR TREATING DISORDERS INCLUDING ALLERGY, INFLAMMATION, HYPERTENSION, SLEEP DISORDERS, ALZHEIMER'S | SCHERING CORPORATION (US) | 1999-08-03 | — | — | US | disclosed |
| US-5463074-A | Treating allergy, inflammation, hypertension, glaucoma, central nervous system disorders | SCHERING CORPORATION (US) | 1995-10-31 | — | — | US | disclosed |
| EP-0618905-B1 | IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES AS HISTAMINE H3 AGONISTS/ANTAGONISTS | SCHERING CORP (US) | 1995-10-04 | — | — | EP | disclosed |
| EP-0619818-A1 | IMIDAZOYLALKYL SUBSTITUTED WITH A SIX MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING. | SCHERING CORP (US) | 1994-10-19 | — | — | EP | disclosed |
| EP-0618905-A1 | IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES AS HISTAMINE H3 AGONISTS/ANTAGONISTS. | SCHERING CORP (US) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993012093-A1 | IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES AS HISTAMINE H3 AGONISTS/ANTAGONISTS | SCHERING CORPORATION (US) | 1993-06-24 | — | — | WO | disclosed |
| WO-1993012108-A1 | IMIDAZOLYL OR IMIDAZOYLALKYL SUBSTITUTED WITH A FOUR OR FIVE MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING | SCHERING CORPORATION (US) | 1993-06-24 | — | — | WO | disclosed |
| WO-1993012107-A1 | IMIDAZOYLALKYL SUBSTITUTED WITH A SIX MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING | SCHERING CORPORATION (US) | 1993-06-24 | — | — | WO | disclosed |
| US-4388467-A | NEUROLEPTIC AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1983-06-14 | — | — | US | disclosed |
| US-4334070-A | NEUROLEPTIC AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1982-06-08 | — | — | US | disclosed |
| EP-0035244-A2 | Cycloalka(4,5)pyrrolo(2,3-g)isoquinolines, processes and intermediates for their preparation, and medicines containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-09-09 | — | — | EP | disclosed |